Health2/20/2026•NYT

MAHA Moms Turn Against Trump: ‘Women Feel Like They Were Lied To’

MAHA Moms Turn Against Trump: ‘Women Feel Like They Were Lied To’

The article discusses the backlash from MAHA (Moms Advocating Healthy Alternatives) against President Trump's executive order that aims to increase production of a pesticide. MAHA, led by Robert F. Kennedy Jr., is a movement that advocates for healthier alternatives. The article states that women in the MAHA movement feel "lied to" by the president's decision, which they believe contradicts his previous statements about prioritizing the health and safety of families. They argue that the increased production of the pesticide poses a threat to public health, particularly for children. The article highlights the growing divide between the Trump administration and the MAHA movement, which has been a vocal critic of the president's policies related to environmental and public health issues. The MAHA leaders are determined to challenge the executive order and continue advocating for their cause.

Source: For the complete article, please visit the original source link below.

Source: NYTEnhanced summary
Share:

Related Articles

Sci-fi surgery as doctor in UK directs robot to remove a prostate in Gibraltar
🏥 HealthMar 6•1 min read

Sci-fi surgery as doctor in UK directs robot to remove a prostate in Gibraltar

'Game-changing' urine tests could detect breast cancer, endometriosis and PCOS
🏥 HealthMar 5•1 min read

'Game-changing' urine tests could detect breast cancer, endometriosis and PCOS

RFK Jr urges medical schools to increase nutrition education training
🏥 HealthMar 5•1 min read

RFK Jr urges medical schools to increase nutrition education training

David Harding obituary
🏥 HealthMar 5•1 min read

David Harding obituary

'Moment of reckoning' needed in social care, says Louise Casey
🏥 HealthMar 5•1 min read

'Moment of reckoning' needed in social care, says Louise Casey

Covid inquiry chair defends £200m cost and four-year process on final day
🏥 HealthMar 5•1 min read

Covid inquiry chair defends £200m cost and four-year process on final day